The Meihua Biont, (600873) late announcement on April 24, a wholly owned subsidiary company of Lhasa holding subsidiary of Meihua Guang Sheng Medicine to apply for stock transfer system of small and medium-sized enterprises in the country(hereinafter referred to as "new three board") cartellino. In addition, wide Guang Sheng medicine proposed increase endowment spread, the Meihua in Lhasa offered $46.2 million to subscribe raw medicine 1.3356 million shares. Before the capital increase, the Meihua in Lhasa holds a 51.761% stake in wide Guang Sheng medicine. After the completion of the capital increase, the Meihua in Lhasa will hold a 50.1342% stake in wide Guang Sheng medicine, is still widely raw medicine's controlling shareholder.
Service hotline:400-960-0873
Group the switchboard:+86 316-2359999
Email:meihua@lulus88.com
Client inquiry|Webs of subsidiary members|Contact Us|Legal Statement|Privacy Protection
Focusing on Biotechnology, Building and Sharing Better FutureCopyRight @ 2005 MEIHUA HOLDINGS GROUP CO., LTD .
Mobile
Registered address: Kim Lhasa Tibet autonomous region west road no. 189
Office address: No.66 Huaxiang Road,Economic and Technical Development Area,Langfang City, Hebei Province 065001, China
The service hotline: 400-960-0873
Tel: +86 316-2359999 Fax: +86 316-2359679
Email:meihua@lulus88.com
URL:lulus88.com